106P Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studies.

Authors :: Yuan, Y.
Deng, Y.
Jin, Y.
Pan, Y.
Wang, C.
Wang, Z.
Zhang, Z.
Meng, X.
Hu, Y.
Zhao, M.
Wang, H.
Yang, N.
Wu, D.
Dong, X.
Huang, D.
Sun, M.
Liu, L.
Hua, D.
Guo, Z.
Ding, K.
Source :: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1512-S1512. 1p.
Publication Year :: 2023

Subjects :: *COLORECTAL cancer
*METASTASIS
*GENETIC mutation
*METASTATIC breast cancer
*SAFETY
*ONCOLOGY

Full Text Access

Tools